View Article

Abstract

The COVID-19 pandemic has highlighted the urgent need for effective prevention and treatment strategies. While there isn't a specific drug that targets the virus, boosting the immune system can greatly improve resistance to infections. Groups at higher risk—like children, the elderly, and individuals with existing health issues—are especially vulnerable to severe consequences. Herbal medicinal plants have gained significant interest for their potential antiviral properties and ability to boost the immune system. Many traditional remedies are currently being investigated as complementary treatments for viral infections, including COVID-19. Some notable examples are Tinospora cordifolia, Echinacea purpurea, Nigella sativa, Caesalpinia sappan, and Isatis indigotica. These plants are rich in various bioactive compounds—such as alkaloids, flavonoids, terpenoids, and polysaccharides—that may influence different stages of the viral life cycle, including entry, replication, and release.

Keywords

COVID-19, Pandemic, Tinospora cordifolia, Echinacea purpurea, Nigella sativa, Caesalpinia sappan, Isatis indigotica

Introduction

The use of herbal drugs in the preparation of ayurvedic medicines is well-documented in the Indian system of traditional medicine (ISTM) and other traditional medicinal practices. In India and neighbouring countries, many people in rural and tribal areas still rely on ISTM. These systems have been in use for over 5,000 years, offering aesthetic value, higher patient compliance, and fewer side effects. ISTM has been developed through the guru-shishya tradition and is referenced in various ayurvedic texts such as the Charak Samhita, Sushruta Samhita, and Kapila Hridayam. Immunity refers to the body's capability to protect itself from disease-causing organisms. Every day, we encounter numerous pathogens, but only a small number lead to illness. This is because our body can produce antibodies that target these pathogens, safeguarding us from diseases. This protective system is known as immunity. Immunity booster is named by various names such as Immunomodulator, Immunostimulatory, Immunopotentiation, etc.

  • Ancient Reference:

Nootropic herbs are a category of medicinal plants recognized in Ayurveda for their numerous benefits, particularly in enhancing immunity. Some of these Ayurvedic herbs include Garlic, Ginger, Cinnamon, Turmeric, Holy Basil, Liquorice, Black Pepper, Ashwagandha, Neem, Betel, Guduchi, Clove, Kalonji, and Jeera, among others.

  • Natural Immunity Booster
  • Food

Eating right diet helps to boost immunity. Leafy greens and cruciferous vegetables like broccoli, cabbage, spinach and kale are recommended by some researchers, as are berries, citrus fruit and garlic and yogurt.

  • Supplements

Dietary supplements and herbal extracts provide concentrated doses of specific vitamins and minerals that may help support immune function, though they are not necessary if you're eating a balanced diet. Some popular supplements for immune support include Vitamin C, Vitamin D, Zinc, etc.

  • Medicinal Plant

A number of herbs traditionally employed in ISTM and other plant-based medicine systems such as Chinese herbal medicine system, Unani medicine system, have yielded positive results [1-3].

2. Immunity Booster Plants

2.1. Tinospora cordifolia

2.1.1. Description

Tinospora cordifolia commonly named as “Guduchi” in Sanskrit belonging to family Menispermaceae is a genetically diverse, large, deciduous climbing shrub with greenish yellow typical flowers, found at higher altitude. [4–6] In racemes or racemose panicles, the male flowers are clustered and female are solitary. The flowering season expands over summers and winters. [7] A variety of active components derived from the plant like alkaloids, steroids, diterpenoid lactones, aliphatics, and glycosides[7] have been isolated from the different parts of the plant body, including root, stem, and whole plant.

Fig 2: Tinospora cordifolia

2.1.2. Chemical Constituents

The chemical constituents of T. cordifolia belong to different classes such as alkaloids, glycosides, steroids, phenolics, aliphatic compounds, polysaccharides; leaves are rich in protein (11.2%), calcium and phosphorus [9]. The stem contains clerodane furono diterpene glucoside (amritoside A, B, C, and D) and the structure has been established by different spectroscopic studies [9,10,11]. Some of the essential constituents reported in and major constituents, whereas the structure of the active chemical constituent for Tinospora cordifolia has been depicted in below figure:

Table 1: Essential constituents of T. cordifolia

Structure 1: Essential constituents of T. cordifolia

2.1.3. Uses

Tinospora Cordifolia is used in various traditional and modern medicinal practices for its therapeutic properties. It is commonly used for Treating Fever, Malaria, and Dengue Fever, boosting the immune system, preventing infections, reducing inflammation and also used as anti-diabetic, anti-periodic, anti-spasmodic, anti-inflammatory, anti-arthritic, anti-oxidant, anti-allergic, anti-stress, anti-leprotic, anti-malarial, hepatoprotective, immunomodulatory and anti-neoplastic activities. 

2.1.4. Marketed Product

As prescribed by the physician.

Contra-indication: None

Side effects: No known side effects

Expiry: 5 years from the date of manufacturing.

Disclaimer: The information provided herein on request, is not to be taken as a replacement for medical advice or diagnosis or treatment of any medical condition. Do Not Self-Medicate. Please Consult Your Physician for Proper Diagnosis and Prescription.

Fig 3: Marketed product of T. cordifolia

2.2. Echinacea purpurea

2.2.1. Description

Echinacea purpurea (L.) Moench is one of the most important and well-known medicinal plants in the world, belonging to the Asteraceae (Compositae) family. Echinacea purpurea is an herbaceous perennial wildflower native to North America. Commonly known as Purple Coneflower, this species typically grows 3′ tall and prefers full sun with well-drained soil. Blooming from summer to fall, this showy flower attracts bees, butterflies and hummingbirds to your garden. This large multi-stemmed perennial will bloom for months beginning in Summer, and extending to frost if deadheaded. The long stems make this an excellent cut-flower. The foliage has a rough texture, and is browsed by rabbits and other herbivores. The native range is meadows, prairies, roadsides, and open woods. Echinacea purpurea has high value to wildlife of all kinds.

Fig: 4: Echinacea purpurea

2.2.2. Chemical constituents

Various compounds belonging to different classes of secondary metabolites have been isolated and identified in E. purpurea extract. Alkamides, caffeic acid derivatives, and polysaccharides are the three major groups of secondary metabolites in the plant, which have been considered mostly in manuscripts. In one study, 10 alkamides, mostly with isobutylamide and 2-methylbutylamide moieties, have been successfully purified from the n-hexane extract of the plant root.[38] Purification of the chloroform extract of the plant root also has resulted in the purification of some alkamides with isobutylamide and 2-methylbutylamide moieties and nitidanin-diisovalerianate as well as a sequesterpene, 1β-hydroxy-4 (15),5E,10 (14)-germacratriene, using chromatographic methods.[39]  Isolated alkamides (with isobutylamides) mostly contained 2,4-dienoic units in their structures.[40] The results of a high-performance liquid chromatography-diode array detector-mass spectrometry (HPLC-DAD-MS) analysis of the roots and aerial parts of the plant showed that the storage conditions and methods of the extraction can significantly influence the contents of cichoric acid and alkamide derivatives.[41] Contents of alkamides and cichoric acid in E. purpurea (root and aerial parts) have been analyzed in different samples, and the results showed that high-quality root contains more than 6 mg/g alkamides, while cichoric acid content for root and aerial parts was evaluated as more than 15 mg/g. The aerial parts of the plant usually cannot be considered as a source of alkamides. For marketing, a minimum standard level could be assumed as > 3 mg/g for alkamides and > 5 mg/g for cichoric acid.[42] Polysaccharides and polyacetylenes along with glycoproteins were also purified from the aerial parts of the plant as well.[40] The juice of the plant contains heterogeneous polysaccharides (MW < 10 kDa), inulin-type fractions (MW = 6 kDa) and acidic highly branched arabinogalactan polysaccharide (MW = 70 kDa). Arabinogalactan-protein isolated from the aerial parts of the plant is composed of 83% polysaccharide (galactose/arabinose), 4-5% uronic acids, and 7% protein, with high concentrations of serine and hydroxyproline. [40,81] Other compounds including alkaloids, amides, and flavonoids (quercetin, kaempferol, isorhamnetin and their free phenolic acids including p-coumaric, p-hydroxybenzoic, and protocatechuic acids) have also been isolated and identified from the plant.

Structure 2: Essential constituents of E. purpurea

 2.2.3. Uses

Echinacea purpurea has reportedly shown good results in treating cancer, boosts the immune system, alleviates pain, used as laxative, anti-inflammatory agent, treats skin problem, improves mental health, relieves upper respiratory issues, fights infections, reduces    cold symptoms and its duration.

2.2.4. Marketed Product

Indications: Low immunity

Net Quantity: 30 mL

Product Form: Liquid drop

Dosage: Adults: Take 2 mL 3 times daily

Children ages 6-12 years of age: Take 1 mL 3 times daily

Intensive: Take 2 mL every 2 hours for first 48 hours. Then take 2 mL 3 times daily for the next 8-9 days.

Fig: 5: Marketed product of E. purpurea

2.3. Nigella sativa

2.3.1 Description

Among medicinal plants, Nigella sativa (N. sativa) (Family Ranunculaceae) is emerging as a miracle herb with a rich historical and religious background since many researches revealed its wide spectrum of pharmacological potential. N. sativa is commonly known as black seed. N. sativa is native to Southern Europe, North Africa and Southwest Asia and it is cultivated in many countries in the world like Middle Eastern Mediterranean region, South Europe, India, Pakistan, Syria, Turkey, Saudi Arabia [45]. The seeds of N. sativa and their oil have been widely used for centuries in the treatment of various ailments throughout the world. And it is an important drug in the Indian traditional system of medicine like Unani and Ayurveda [46], [47]. Among Muslims, it is considered as one of the greatest forms of healing medicine available due to it was mentioned that black seed is the remedy for all diseases except death in one of the Prophetic hadith. It is also recommended for use on regular basis in Tibb-e-Nabwi (Prophetic Medicine) [48].

Fig: 6: Nigella sativa

2.3.2. Chemical constituents

Many active compounds have been isolated, identified and reported so far in different varieties of black seeds. The most important active compounds are thymoquinone (30%-48%), thymohydroquinone, dithymoquinone, p-cymene (7%-15%), carvacrol (6%-12%), 4-terpineol (2%-7%), t-anethol (1%-4%), sesquiterpene longifolene (1%-8%) α-pinene and thymol etc. Black seeds also contain some other compounds in trace amounts. Seeds contain two different types of alkaloids; i.e. isoquinoline alkaloids e.g. nigellicimine and nigellicimine-N-oxide, and pyrazol alkaloids or indazole ring bearing alkaloids which include nigellidine and nigellicine. Moreover, N. sativa seeds also contain alpha-hederin, a water soluble pentacyclic triterpene and saponin, a potential anticancer agent [49], [50]. Some other compounds e.g. carvone, limonene, citronellol were also found in trace amounts. Most of the pharmacological properties of N. sativa are mainly attributed to quinine constituents, of which TQ is the most abundant. On storage, TQ yields dithymoquinone and higher oligocondensation products. The seeds of N. sativa contain protein (26.7%), fat (28.5%), carbohydrates (24.9%), crude fibre (8.4%) and total ash (4.8 %). The seeds are also containing good amount of various vitamins and minerals like Cu, P, Zn and Fe etc. The seeds contain carotene which is converted by the liver to vitamin A. Root and shoot are reported to contain vanillic acid [49], [51].  The seeds reported to contain a fatty oil rich in unsaturated fatty acids, mainly linoleic acid (50-60%), oleic acid (20%), eicodadienoic acid (3%) and dihomolinoleic acid (10%). Saturated fatty acids (palmitic, stearic acid) amount to about 30% or less. α-sitosterol is a major sterol, which accounts for 44% and 54% of the total sterols in Tunisian and Iranian varieties of black seed oils respectively, followed by stigmasterol (6.57-20.92% of total sterols) [52-54].  Examples of various other reported chemical components includes nigellone,avenasterol-5-ene, avenasterol-7-ene, campesterol, cholesterol, citrostadienol, cycloeucalenol,, gramisterol, lophenol, obtusifoliol, stigmastanol, stigmasterol-7-ene, β-amyrin, butyro-spermol, cycloartenol, 24-methylene-cycloartanol, taraxerol, tirucallol, 3-O-[β-D-xylopyranosyl(1→3)-α-L-rhamnopyranosyl(1→2)-α-L-arabino-pyranosyl]-28-O-[α-L-rhamnopyranosyl(1→4)-β-D glucopyranosyl(1→6)-β-D-gluco-pyranosyl] hederagenin, volatile oil (0.5-1.6%), fatty oil (35.6-41.6%), oleic acid, esters of unsaturated fatty acids with C15 and higher terpenoids, esters of dehydrostearic and linoleic acid, aliphatic alcohol, β-unsaturated hydroxy ketone, hederagenin glycoside, melanthin, melanthigenin, bitter principle, tannin, resin, protein, reducing sugar, glycosidal saponin, 3-O-[β-D-xylopyranosyl-(1→2)-α-L-rhamno-pyranosyl-(1→2)-β-D-glucopyranosyl]-11-methoxy-16, 23-dihydroxy-28-methy-lolean-12-enoate,stigma-5, 22-dien-3-β-D-gluco-pyranoside, cycloart-23-methyl-7, 20, 22-triene-3β, 25-diol, nigellidine-4-O-sulfite, N. mines A3, A4, A5, C, N. mines A1, A2, B1, and B2[55-59].

Structure 3: Essential constituents of N. sativa

2.3.3. Uses

N. sativa is used to lowers high blood sugar, controls type-II diabetes, promotes liver health, boosts memory, treats asthma, boosts immunity, enhances skin complexation, treats hair loss and also reduces cancer risk.

2.3.4. Marketed Product

Safety Information

Don't exceed recommended dose. Not intended for pregnant or nursing mothers or children under the age of 18. Speak to your doctor before taking any supplement. This product contains herbal ingredients which may cause allergic reactions for sensitive users. Some may also experience side effects such as migraines and nausea. Discontinue use immediately if you experience these symptoms.

Ingredients; Cold Pressed Black Seed Oil Cumin

Directions: 2 capsules taken daily preferably with meals or as directed by a healthcare professional.

Fig 7: Marketed product of N. sativa

2.4. Caesalpinia sappan

2.4.1. Description

Caesalpinia sappan Linn. or Sappanwood belonging to the Leguminosae family is a redwood full-fledged in numerous regions of Southeast Asia. Caesalpinia sappan is a small to medium-sized, shrubby tree, 4-8(-10) m tall; trunk up to 14 cm in diameter; bark with distinct ridges and many prickles, greyish brown; young twigs and buds hairy, brownish. Flowering can occur after 1 year of growth and usually during the rainy season, fruiting about 6 months later. In Myanmar, the tree flowers in August, and in Indonesia pods are produced 13 months after planting. The medicinal properties of sappanwood (C. sappan) were documented in the Indian Ayurveda, Chinese traditional herbs (Efferth et al., 2008), Japanese pharmacopeia, medicinal plants in Vietnam, and medicinal Thai plants (Kennedy et al., 2004).   

   

Fig 8: Caesalpinia sappan

2.4.2. Chemical constituents

The phytochemical composition of sappan wood has been studied extensively, and it has been found that it contains various bioactive compounds. The major constituents of sappan wood are flavonoids, phenolic acids, and anthraquinones.  Other substances found in sappan wood, in addition to flavonoids and phenolic ones, are triterpenoids, steroids, alkaloids, saponins, and tannins. Many different biological actions, such as anti-inflammation, anticancer, and antioxidant characteristics, are exhibited by the class of polyphenolic compounds and have been connected to several health benefits [60]. Several structurally unique phenolic components, such as brazilin, xanthone, one coumarin, chalcones, flavones, and homo isoflavonoids, are present in sappan wood [61-62].

Structure 4: Essential constituents of C. sappan

2.4.3. Uses

Tinospora Cordifolia is used in various traditional and modern medicinal practices for its therapeutic properties. It is commonly used for its antimicrobial properties, as powerful antioxidants, for metabolic diseases, for its antiulcer properties, for antiplatelet properties, for anticancer properties, for skin care, for its anti-inflammatory properties, to boost immunity, etc.

2.4.4. Marketed Product

Usage: For filling into capsules or tablets form.
Condition: New
Packaging: 50 g

Fig 9: Marketed product of C. sappan

2.5. Isatis indigotica

2.5.1. Description

Isatis indigotica Fort. (I. indigotica) is an herbaceous plant belonging to Cruciferae family. Its leaf (IIL) and root (IIR) are commonly used in traditional Chinese medicines (TCMs) with good clinical efficacies such as clearing away heat and detoxification, cooling blood and reducing swelling.

  

 

Fig 10: Isatis Indigotica

2.5.2. Chemical constituents

  • Leaf:

The fresh leaves contain isatan B, 3-indlymethyglucosinolate, glucobrassicin, neoglucobrassicin, 1-sulpho-3-indolymethy glucosinolate. [63] While the dried leaves contain alkaloids, including indigotin, indirubin, [64] 2,4(1H,3H)-quinazolinedion, 5-hydroxy-2-indolinone, 10H-indolo[3,2-b] quinolone, [65] 4(3H)-quinazolinone, deoxyvascinone, tryptanthrin, [66] Isatisine A. [67] Indigotin and indirubin are fat-soluble compounds displaying poor solubility and are only soluble in chloroform, acetone and other organic solvents. They have a life span of only 24 hours in the dark after which they begin to decompose. [68] Some of the other components in the leaves are: (1) Organic acids: [69,70] 3,5-dimethoxy-4-hydroxy benzoin acid, syringic acid, nicotic acid, succinic acid, salicylic acid, anthranilic acid. (2) Flavonoids: [71] isovitexin, 6-β-D-glucopyranosyldiosmetin. (3) Lignans: [72] (-)-lariciresinol, (+)-isolariciresinol. (4) Nucleosides: [73] uridine, adenosine, xanthine, hypoxanthine. (5) Steroids: [74] β-rosasterol, β-sitosterol, γ-sitosterol. (6) Amino acid: [75] L-pyroglutamic acid. (7) Minerals: [76] Iron, titanium, manganese, zinc, copper, cobalt, nickel, selenium, chromium, arsenic, etc. There is also volatile oil components present in folium isatidis.

  • Roots:

The roots include the following chemical constituents (1) Alkaloids: indigotin, isatin, indirubin, [64] indoxyl-β-glucoside, 2,5-dihydroxy-indole, 2,3-dihydro-4-hydroxy-2-oxo-indole-3-acetonitrile, indole-3-acetonitrile-6-O-β-D-glucopyranoside,[77] hydroxyindirubin, isaindigodione, (E)-3-(3',5'-dimethoxy-4'-hydroxybenzylidene)-2-indolinone, 3-formyl-indole, deosyvasicinone, isaindigotone, tryptanthrin,[78] 3-(2'-carboxyphenyl)-4(3H)-quinazolinone, 4(3H)- quinazolinone, 3-(2'-hydroxyphenyl)-4(3H)-quinazolinone, isaindig otidione, Isatan A,[79] 3-[2'-(5'-hydroxymethyl)furyl]-1(2H)-isoquinolinone-7-O-β-D-glucoside, 2,3-dihydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5,11(10H,11aH)-dione.[80] (2) Flavonoids: [81-83] neohesperidin, liquiritigenin, isoliquiritigenin, isovitexin, linarin, eupatorin. (3) Lignans: [72] (-)-lariciresinol, lariciresinol-4-O-β-D-glucopyranoside, lariciresinol-4,4'-di-O-β-D-glucopyranoside, 4-(1,2,3-trihydroxypropyl)-2, 6-dimethoxyphenyl-1-O-β-D-glucopyranoside, syringin, (+)-isolariciresinol. (4) Organic acids: [84] 3-pyridinecarboxylic acid, maleic acid, 2-hydroxy-1,4-benzenedicarboxylic acid, benzoic acid, salicylic acid, syringic acid, palmitic acid, succinic acid, 2-amino benzoic acid, 5-hydroxymethyl furoic acid. (5) Anthraquinones: [85] emodin, emodin-8-O-β-D-glucoside. (6) Steroids: [86] β-sitosterol, daucosterol, γ-sitosterol. (7) Sinigrins: [87] 3-indolylmethyl gluosinolate, neoglucobrassicin, 1-sulpho-3-indolylmethylgluosinolate. (8) Sulfur compounds: [88] epigoitrin, 1-thiocyano-2-hydroxy-3-butene. (9) Amino acids: [89] praline, arginine, tyrosine, valine, glutamic acid, γ-aminobutyric acid, leucine, tryptophan, aspartic acid, L-threonine, β-hydroxyalanine, glycine, isoleucine, phenylalanine, histidine, lysine. (10) Nucleotides: [90] uridine, hypoxanthine, uracil, adenosine, guanine. (11) Others: [91-94] ammonium formate, sucrose, 5-hydroxymethyl-furaldehyde, n-butyl-O-β-D-fructopyranose, mannitol, pyrophaeophorbideα, polygalitol.

Structure 5: Essential constituents of I. indigotica

2.5.3. Uses

Isatis indigotica have been widely used in combination with other Chinese medicines to treat and prevent a variety of diseases such as influenza, parotitis, epidemic encephalitis B, epidemic myelitis, epidemic cerebrospinal meningitis, acute infectious hepatitis and sore throat. [95,96] Iindigotica, display many important pharmacological activities such as liver protection and anti-microbial, and indirubin also has anti-tumor effects. [97] It shows various pharmacological properties such as anti-viral activity, antibacterial activity, anti-endotoxin, Immunopotentiation, anti-inflammation, anti-tumour, etc.

2.5.4. Marketed Product

Concentration/Other Ingredients: 1:4 - Certified Organic Alcohol, Distilled Water

Suggested Use: 30-60 Drops (1.5-3 Ml) In Juice or Water. Take 3 Times Per Day.

Contraindications: None

Fig 11: Marketed product of I. indigotica

PHYSICAL EXERCISE

Regular moderate exercise improves the immunity of the body and reduces inflammation.
Achieve at least 30 minutes of moderate physical activity most days of the week.
Use a combination of aerobic exercise, strength, and mind-body exercises.
Limit and not over-trained, so as to prevent suppression of immunity.
Hydrate yourself; consume nutrient-dense foods; manage your levels of stress.

ANALYSIS OF HERBAL DRUGS

Formulations containing either isolated phytoconstituents extracts or parts or whole drug are analyzed by routine quality control techniques. The quality control techniques include high performance thin layer chromatography, high performance liquid chromatography, UV-spectrophotometry, gas chromatography, etc [48-66].

CONCLUSION

Medicinal plants are rich source of bioactive phytochemicals, characterized by multiple and often pleiotropic activities, which can be exploited both therapeutically and as nutraceutical strategies for preventive purpose. Among plant-based nutraceuticals, immunomodulators have been highlighted to be of interest of boosters of the immune system to counteract infections or exogenous injuries, immunosuppressor, to control the abnormal immune response occurring during autoimmune diseases, or as adjuvants, which contribute by modulating nonimmune targets. Thus, these medicinal plants are effective in boosting the immune system. In addition, it is advised that the quality of good lifestyle will be ensured with appropriate herbal extract treatment to boost immunity followed with proper diet, and mindfulness to support all along.

REFERENCES

  1. Bhowmik D, Chiranjib, Tiwari P, Tripathi KK, Sampath KP. Traditional Indian memory enhancer herbs and their medicinal importance. Annals of Biological Research. 2010; 1(1): 41-46.
  2. Raj D, Ganapathy D. Herbal nootropic agents. Drug Invention Today. 2019; 12(10): 2333-37.
  3. Birks J, Grimley JE, Van MD. Ginkgo biloba for Cognitive Impairment and Dementia (Cochrane Review). In: The Cochrane Library. 2002; 4.
  4. Rana V, Thakur K, Sood R, Sharma V, Sharma TR. Genetic diversity analysis of Tinospora cordifolia germplasm collected from northwestern Himalayan region of India. J Genet. 2012; 91:99–103.
  5. Parthipan M, Aravindhan V, Rajendran A. Medico-botanical study of Yercaud hills in the eastern Ghats of Tamil Nadu, India. Anc Sci Life. 2011; 30:104–9.: Department Of AYUSH, Ministry of Health and FW; 2001. pp. 53–5.
  6. The Ayurvedic Pharmacopoeia of India. Part I. 1st ed. Vol. 1. New Delhi: Department Of AYUSH, Ministry of Health and FW; 2001. pp. 53–5
  7. Upadhyay AK, Kumar K, Kumar A, Mishra HS. Tinospora cordifolia (Willd.) Hook. f. and Thoms. (Guduchi)-validation of the Ayurvedic pharmacology through experimental and clinical studies. Int J Ayurveda Res. 2010; 1:112–21.
  8. Chaudhary N., Siddiqui M.B., Khatoon S. Pharmacognostical evaluation of Tinospora cordifolia (Willd) Meirs and identification of biomarkers. J. Res. Indian Med. 2014; 13:543–550.
  9. Maurya R., Manhas L.R., Gupta P., Mishra P.K., Singh G., Yadav P.P. Amritosides A, B, C and D: clerodane furano diterpene glucosides from Tinospora cordifolia. Phytochemistry. 2004; 5:2051–2055.
  10. Abhijeet R., Mokat D. On vegetative propagation through stem cuttings in medicinally lucrative Tinospora species. J. Pharmacogn. Phytochem. 2018; 2:2313–2318.
  11. Sumran G., Aggarwal A. Prospect of Indian herbs as sources of antioxidants incombating oxidative stress. Chem. Biol. Interface. 2019; 9:1–20.
  12. Khuda M.Q.I., Khaleque A., Ray N. Tinospora cordifolia constituents of plants fresh from the field. Sci. Res. 1964; 1:177–183.
  13. Hanuman J.B., Bhatt R.K., Sabata B.K. A diterpenoid furanolactone from Tinospora cordifolia. Phytochemistry. 1986; 25:1677–1680.
  14. Bhatt R.K., Hanuman J.B., Sabata B.K. A new clerodane derivative from Tinospora cordifolia. Phytochemistry. 1988; 27:1212–1216.
  15. Hanuman J.B., Bhatt R.K., Sabata B. A clerodane furano-diterpene from Tinospora cordifolia. J. Nat. Prod. 1988; 51:197–201.
  16. Bhatt R.K., Sabata B.K. A furanoid diterpene glucoside from Tinospora cordifolia. Phytochemistry. 1989; 28:2419–2422.
  17. Khan M.A., Gray I.A., Waterman P.G. Tinosporaside an 18-norclerodane glucoside from Tinospora cordifolia. Phytochemistry. 1989; 28:273–275.
  18. Gangan V.D., Arjun P.P., Sipahimalani T., Banerji A., Cardifolisides A., B C. Norditerpene furon glucoside from Tinospora cordifolia. Phytochemistry. 1994; 37:781–786.
  19. Maurya R., Handa S.S. Tinocordifolin, a sesquiterpene from Tinospora cordifolia. Phytochemistry. 1998; 44:1343–1345.
  20. Gangan V.D., Arjun P.P., Sipahimalani A.T., Banerji A. Norditerpene furon glucoside from Tinospora cordifolia. Phytochemistry. 1995; 39:1139–1142.
  21. Wazir V., Maurya R., Kapil R.S. A clerodane furano diterpene glucoside from Tinospora cordifolia. Phytochemistry. 1995; 38:447–449.
  22. Gagan V.D., Pradhan P., Sipahimalan A.T., Banerji A., Palmatosides C F. Diterpene furan glucosides from Tinospora cordifolia-structural elucidation by 2D NMR spectroscopy. Indian J. Chem. 1996;35B:630–634.
  23. Choudhary N., Siddiqui M.B., Azmat S., Khatoon S. Tinospora cordifolia: ethnobotany, phytopharmacology and phytochemistry aspects. IJPSR. 2013; 4:891.
  24. Bisset N.G., Nwaiwu J. Quaternary alkaloids of Tinospora species. Planta Med. 1983; 48:275–279.
  25. Mahajan V.R., Jolly C.I., Kundnani K.M. A new hypoglycaemic agent from Tinospora cordifolia. Indian Drugs. 1985; 23:119–120.
  26. Sarma D.N.K., Khosa R.L., Chansauria J.P.N., Ray A.K. The effect of Tinospora cordifolia on brain neurotransmitters in the stressed rat. Fitoterapia. 1995; 66:421–422.
  27. Pathak A.K., Agarwal A.K., Jain D.C., Sharma R.P., Howarth O.W. NMR studies of 20 hydroxyecdysones, a steroid isolated from Tinospora cordifolia. Indian J. Chem. 1995; 34:674–676
  28. Hanuman J.B., Mishra A.K., Sabata B. A natural phenolic lignan from Tinospora cordifolia Miers. J. Chem. Soc. 1986:1181–1185.
  29. Kidwai A.R., Salooja K.C., Sharma V.N., Siddiqui S. Chemical examination of Tinospora cordifolia. J. Sci. Indian Res. 1949; 8:115–118.
  30. Khaleque A., Maith M.A.W., Huq M.S., K Abul B. Tinospora cordifolia IV. Isolation of heptacosanol, ß sitosterol and three other compounds tinosporine, cordifol and cordifolone. Pakistan J. Sci.Industry Res. 1970;14:481–483.
  31. Dixit S.N., Khosa R.L. Chemical investigations on Tinospora cordifolia (wild.) miers. Indian. J. Appl. Chem. 1971; 34:46–47.
  32. Pathak A.K., Jain D.C., Sharma P.R. Chemistry and biological activities of the genus Tinospora. Int. J. Pharmacogn. 1995; 33:277–287.
  33. Khuda M.Q., Khaleque A., Basar K.A., Rouf M.A., Khan M.A., Roy N. Studies on Tinospora cordifolia II: isolation of tinosporine, tinosporic acid and tinosporol from the fresh creeper. Sci. Res. 1966; 3:9–12.
  34. Khaleque A., Maith M.A.W., Huq M.S., Tinospora cordifolia K.A., III Isolation of tinosporine, heptacosanol, ß sitosterol. Pakistan J. Sci. Industry Res. 1971; 14:481–483.
  35. Maurya R., Wazir V., Tyagi A., Kapil R.S. Clerodane diterpene from Tinospora cordifolia. Phytochemistry. 1995; 38:659–661.
  36. Pradhan P., Gangan V.D., Sipahimalani A.T., Banerji A. Two phytoecdysones from Tinospora cordifolia: structural assignment by 2D NMR spectroscopy. Indian J. Chem. 1997;36B:958–962.
  37. Chintalwar G., Jain A., Sipahimalani A., Banerji A., Sumariwalla P., Ramakrishnan R., Sainis K. An Immunologically active arabinogalactan from Tinospora cordifolia. Phytochemistry. 1999; 52:1089–1093.
  38. Bauer R, Remiger P, Wagner H. Alkamides from the roots of Echinacea purpurea. Phytochemistry. 1988; 27:2339–42.
  39. Hohmann J, Rédei D, Forgo P, Szabó P, Freund TF, Haller J, et al. Alkamides and a neolignan from purpurea roots and the interaction of alkamides with G-protein-coupled cannabinoid receptors. Phytochemistry. 2011; 72:1848–53.
  40. Barnes J, Anderson LA, Gibbons S, Phillipson JD. Echinacea species (Echinacea angustifolia (DC.). Hell, Echinacea pallida (Nutt.) Nutt Echinacea purpurea (L.) Moench): A review of their chemistry, pharmacology and clinical properties. J Pharm Pharmacol. 2005; 57:929–54.
  41. Luo XB, Chen B, Yao SZ, Zeng JG. Simultaneous analysis of caffeic acid derivatives and alkamides in roots and extracts of Echinacea purpurea by high-performance liquid chromatography-photodiode array detection-electrospray mass spectrometry. J Chromatogr A. 2003; 986:73–81.
  42. Wills RB, Stuart DL. Alkylamide and cichoric acid levels in Echinacea purpurea grown in Australia. Food Chem. 1999; 67:385–8.
  43. Classen B, Witthohn K, Blaschek W. Characterization of an arabinogalactan-protein isolated from pressed juice of Echinacea purpurea by precipitation with the beta-glucosyl Yariv reagent. Carbohydr Res. 2000; 327:497–504.
  44. Bohlmann F, Hoffmann H. Further amides from Echinacea purpurea. Phytochemistry. 1983; 22:1173–5.
  45. Khare CP. Encyclopedia of Indian medicinal plants. NewYork: Springes-Verlag Berlin Heidelberg; 2004.
  46. Sharma PC, Yelne MB, Dennis TJ. Database on medicinal plants used in Ayurveda. New Delhi: 2005. pp. 420–440.
  47. Goreja WG. Black seed: nature's miracle remedy. New York, NY: Amazing Herbs Press; 2003.
  48. Al-Bukhari MI. In: The collection of authentic sayings of prophet mohammad (peace be upon him), division 71 on medicine. 2nd ed. Al-Bukhari Sahi., editor. Ankara: Hilal Yayinlari; 1976.
  49. Al-Jassir MS. Chemical composition and microflora of black cumin (Nigella sativa L.) seeds growing in Saudi Arabia. Food Chem. 1992; 45:239–242.
  50. Atta-Ur-Rahman Nigellidine-a new indazole alkaloid from the seed of Nigella sativa. Tetrahedron Lett. 1995;36(12):1993–1994.
  51. Nickavar B, Mojab F, Javidnia K, Amoli MA. Chemical composition of the fixed and volatile oils of Nigella sativa L. from Iran. Z Naturforsch C. 2003;58(9–10):629–631.
  52. Cheikh-Rouhou S, Besbes S, Lognay G, Blecker C, Deroanne C, Attia H. Sterol composition of black cumin (Nigella sativa L.) and Aleppo pine (Pinus halpensis Mill.) seed oils. J Food Comp Anal. 2008;21(2):162–168.
  53. Mehta BK, Verma M, Gupta MJ. Novel lipid constituents identified in seeds of Nigella sativa Linn. Braz Chem Soc. 2008;19(3):458–462.
  54. Bourgou S, Ksouri R, Bellila A, Skandrani I, Falleh H, Marzouk B. Phenolic composition and biological activities of Tunisian Nigella sativa L. shoots and roots. C R Biol. 2008;331(1):48–55.
  55. Nickavar B, Mojab F, Javidnia K, Amoli MA. Chemic al composition of the fixed and volatile oils of Nigella sativa L. from Iran. Z Naturforsch C. 2003;58(9–10):629–631.
  56. Morikawa T, Xu F, Ninomiya K, Matsuda H, Yoshikawa M. N.mines A3, A4, A5 and C, new dolabellane-type diterpene alkaloids with lipid metabolism-promoting activities from the Egyptian medicinal food black cumin. Chem Pharm Bull. 2004;52(4):494–497.
  57. Morikawa T, Xu F, Kashima Y, Matsuda H, Ninomiya K, Oshikawa M. Noveldolabellane-type diterpene alkaloids with lipid metabolism promoting activities from the seeds of Nigella sativa. Org Lett. 2004;6(6):869–872.
  58. Ali Z, Ferreira D, Carvalho P, Avery MA, Khan IA. Nigellidine-4-O-sulfite, the first sulfated indazole-type alkaloid from the seeds of Nigella sativa. J Nat Prod. 2008;71(6):1111–1112.
  59. Mehta BK, Pandit V, Gupta M. New principles from seeds of Nigella sativa. Nat Prod Res. 2009;23(2):138–48.
  60. Shan, T.; Ma, Q.; Guo, K.; Liu, J.; Li, W.; Wang, F.; Wu, E. Xanthones from mangosteen extracts as natural chemopreventive agents: Potential anticancer drugs. Curr. Mol. Med. 2011,11, 666–677.
  61. Nirmal, N.P.; Rajput, M.S.; Prasad, R.G.; Ahmad, M. Brazilin from Caesalpinia sappan heartwood and its pharmacological activities: A review. Asian Pac. J. Trop. Med. 2015,8, 421–430.
  62. Niu, Y.; Wang, S.; Li, C.; Wang, J.; Liu, Z.; Kang, W. Effective compounds from Caesalpinia sappan L. on the tyrosinase in vitro and in vivo. Nat. Prod. Commun. 2020,15, 1934578X20920055. [CrossRef]
  63. Goreja WG. Black seed: nature's miracle remedy. New York, NY: Amazing Herbs Press; 2003.
  64. Al-Ali A, Alkhawajah AA, Randhawa MA, Shaikh NA. Oral and intraperitoneal LD50 of thymoquinone, an active principle of Nigella sativa, in mice and rats. J Ayub Med Coll Abbottabad. 2008;20(2):25–27.
  65. Warrier PK, Nambiar VPK, Ramamurthy. Chennai: Orient Longman Pvt Ltd; 2004. Indian medicinal plants-a compendium of 500 species; pp. 139–142
  66. Al-Jassir MS. Chemical composition and microflora of black cumin (Nigella sativa L.) seeds growing in Saudi Arabia. Food Chem. 1992; 45:239–242.
  67. Atta-Ur-Rahman Nigellidine-a new indazole alkaloid from the seed of Nigella sativa. Tetrahedron Lett. 1995;36(12):1993–1994.
  68. Nickavar B, Mojab F, Javidnia K, Amoli MA. Chemical composition of the fixed and volatile oils of Nigella sativa L. from Iran. Z Naturforsch C. 2003;58(9–10):629–631.
  69. Cheikh-Rouhou S, Besbes S, Lognay G, Blecker C, Deroanne C, Attia H. Sterol composition of black cumin (Nigella sativa L.) and Aleppo pine (Pinus halpensis Mill.) seed oils. J Food Comp Anal. 2008;21(2):162–168.
  70. Mehta BK, Verma M, Gupta MJ. Novel lipid constituents identified in seeds of Nigella sativa Linn. Braz Chem Soc. 2008;19(3):458–462.
  71. Bourgou S, Ksouri R, Bellila A, Skandrani I, Falleh H, Marzouk B. Phenolic composition and biological activities of Tunisian Nigella sativa L. shoots and roots. C R Biol. 2008;331(1):48–55.
  72. Nickavar B, Mojab F, Javidnia K, Amoli MA. Chemic al composition of the fixed and volatile oils of Nigella sativa L. from Iran. Z Naturforsch C. 2003;58(9–10):629–631.
  73. Morikawa T, Xu F, Ninomiya K, Matsuda H, Yoshikawa M. N.mines A3, A4, A5 and C, new dolabellane-type diterpene alkaloids with lipid metabolism-promoting activities from the Egyptian medicinal food black cumin. Chem Pharm Bull. 2004;52(4):494–497.
  74. Morikawa T, Xu F, Kashima Y, Matsuda H, Ninomiya K, Oshikawa M. Novel dolabellane-type diterpene alkaloids with lipid metabolism promoting activities from the seeds of Nigella sativa. Org Lett. 2004;6(6):869–872.
  75. Ali Z, Ferreira D, Carvalho P, Avery MA, Khan IA. Nigellidine-4-O-sulfite, the first sulfated indazole-type alkaloid from the seeds of Nigella sativa. J Nat Prod. 2008;71(6):1111–1112.
  76. Mehta BK, Pandit V, Gupta M. New principles from seeds of Nigella sativa. Nat Prod Res. 2009;23(2):138–48.
  77. Liu YH, Qin GW, Ding SP, et al.  Chemical constituents of isatis root (I). Chin Herb Med 2001; 32(12): 4–7. https://doi.org/CNKI:SUN:ZCYO.0.2001-12-000
  78. Ding SP, Liu YH, Li J, et al.  Study on chemical constituents of isatis root (II). Med J 2001; 020(008): 475–6. 10.3870/j.issn.1004-0781.2001.08.001
  79. Fang JG, Wang SB, Xu H, et al.  Chemical constituents of isatis root (I). Chin Herb Med 2004; 35(8): 9–10. 10.7501/j.issn.0253-2670.2004.8.387.
  80. Liu HL, Wu LJ, Li H, et al.  Chemical constituents of Radix isatidis. J Shenyang Pharm Univ 2002; (02):93–5. 10.3969/j.issn.1006-2858.2002.02.005
  81. Liang Y N, Zhu J, Tang ZS, Sun XC, et al.  Optimization of ultrasonic extraction process and antioxi-dant activity of total flavonoids from Radix isatidis by box Behnken re-sponse surface methodology. J Changchun Univ Trad Chin Med 2019; 35: 119–24. 10.13463/j.cnki.cczyy.2019.01.036
  82. Zhang H J, He LW, Tang M. Molecular docking study on anti influenza virus of flavonoids in isatis root. Chem Time 2018; 32: 19–21. 10.16597/j.cnki.issn.1002-154x.2018.03.007
  83. Zhao WT. Optimization of ultrasonic assisted extraction technology and antioxidant activity of Flavonoids from Isatis indigotica root by response surface methodology. Chin Modern Appl Pharm 2016; 33: 313–7. 10.13748/j.cnki.issn1007-7693.2016.03.013
  84. Liu YH, Ding SP, Wu XY, et al.  Study on chemical constituents of isatis root (III). Chin Herb Med 2002; 33(002): 3–5. 10.7501/j.issn.0253-2670.2002.2.041
  85. Liu YH, Qin GW, Wu XY, et al.  Study on chemical constituents of isatis root (IV). Med J 2003; 22(9): 591–4. https://doi.org/CNKI:SUN:YYDB.0.2003-09-
  86. Chen Y, Fan CL, Wang Y, et al.  Chemical constituents of Radix isatidis. Chin J Trad Chin Med 2018; 43: 2091–6. 10.19540/j.cnki.cjcmm.20180116.001
  87. Liu LF, Li FZ. Chemical composition, pharmacology and quality control management of Radix Isatidis. Chin Health Indu 2018; 15: 36–7. 10.16659/j.cnki.1672-5654.2018.13.036
  88. Sun Q, Zhao J, Zhang SJ, et al. Chemical constituents of isatis root Radix isatidis. Chin J Exp Pharmacol 2012; 18: 74–5. 10.1007/978-1-4020-9623-5-5
  89. Wang XL, Chen MH, Wang F, et al.  Studies on the chemical constituents of Radix isatidis. In: 9th Natural organic chemistry academic conference of China Chemical Society, Haikou, Hainan, China, 2012.
  90. Liu YH, Wu XY, Fang JG, et al.  Study on chemical constituents of Radix isatidis (V). Zhongnan Pharm 2003; 1(5): 302–5. https://doi.org/CNKI:SUN:ZNYX.0.2003-05-017
  91. Yan J. Study on chemical constituents and activity evaluation of radix isatidis and Flaxseed[D]. Jilin University, 2011.
  92. Wang T, Wang X, Zhuo Y, et al.  Antiviral activity of a polysaccharide from Radix isatidis (Isatis indigotica Fortune) against hepatitis B virus (HBV) in vitro via acti-vation of JAK/STAT signal pathway. J Ethnopharmacology 2020;257: 112782. 10.1016/j.jep.2020.112782
  93. Kurihara H, Luo Z, Liu LF, et al.  Isatis indigotica Epigoitrin, an alkaloid from reduces H1N1 infection in stress-induced susceptible model in vivo and in vitro. Front Pharmacol 2019; 10: 78. 10.3389/fphar.2019.00078
  94. Tsai FJ, Hsieh CC, Tsai CH, et al.  Anti-SARS coronavirus 3C-like protease effects of Isatis ndigotica root and plant-derived phenolic compounds. Antiv Res 2005; 68: 36–42. 10.1016/j.antiviral.2005.07.002
  95. Qu RJ, et al.  Selection of reference genes for the quantitative real-time PCR normalization of gene expression in Isatis indigotica fortune. BMC Mol Biol 2019; 20: 9. 10.1186/s12867-019-0126-y
  96. Yan ZH. Clinical practical Chinese medicine[M]. Beijing: People’s Health Publishing House; 1984. ISBN: 14048–519.
  97. Li HY, Li YG, Liang QY, et al.  Extraction and content comparison of indigo and indirubin in Isatis indigotica root, stem and leaf. Guangdong Chem 2016; 43: 27–8. https://doi.org/CNKI:SUN:GDHG.0.2016-02-012.

Reference

  1. Bhowmik D, Chiranjib, Tiwari P, Tripathi KK, Sampath KP. Traditional Indian memory enhancer herbs and their medicinal importance. Annals of Biological Research. 2010; 1(1): 41-46.
  2. Raj D, Ganapathy D. Herbal nootropic agents. Drug Invention Today. 2019; 12(10): 2333-37.
  3. Birks J, Grimley JE, Van MD. Ginkgo biloba for Cognitive Impairment and Dementia (Cochrane Review). In: The Cochrane Library. 2002; 4.
  4. Rana V, Thakur K, Sood R, Sharma V, Sharma TR. Genetic diversity analysis of Tinospora cordifolia germplasm collected from northwestern Himalayan region of India. J Genet. 2012; 91:99–103.
  5. Parthipan M, Aravindhan V, Rajendran A. Medico-botanical study of Yercaud hills in the eastern Ghats of Tamil Nadu, India. Anc Sci Life. 2011; 30:104–9.: Department Of AYUSH, Ministry of Health and FW; 2001. pp. 53–5.
  6. The Ayurvedic Pharmacopoeia of India. Part I. 1st ed. Vol. 1. New Delhi: Department Of AYUSH, Ministry of Health and FW; 2001. pp. 53–5
  7. Upadhyay AK, Kumar K, Kumar A, Mishra HS. Tinospora cordifolia (Willd.) Hook. f. and Thoms. (Guduchi)-validation of the Ayurvedic pharmacology through experimental and clinical studies. Int J Ayurveda Res. 2010; 1:112–21.
  8. Chaudhary N., Siddiqui M.B., Khatoon S. Pharmacognostical evaluation of Tinospora cordifolia (Willd) Meirs and identification of biomarkers. J. Res. Indian Med. 2014; 13:543–550.
  9. Maurya R., Manhas L.R., Gupta P., Mishra P.K., Singh G., Yadav P.P. Amritosides A, B, C and D: clerodane furano diterpene glucosides from Tinospora cordifolia. Phytochemistry. 2004; 5:2051–2055.
  10. Abhijeet R., Mokat D. On vegetative propagation through stem cuttings in medicinally lucrative Tinospora species. J. Pharmacogn. Phytochem. 2018; 2:2313–2318.
  11. Sumran G., Aggarwal A. Prospect of Indian herbs as sources of antioxidants incombating oxidative stress. Chem. Biol. Interface. 2019; 9:1–20.
  12. Khuda M.Q.I., Khaleque A., Ray N. Tinospora cordifolia constituents of plants fresh from the field. Sci. Res. 1964; 1:177–183.
  13. Hanuman J.B., Bhatt R.K., Sabata B.K. A diterpenoid furanolactone from Tinospora cordifolia. Phytochemistry. 1986; 25:1677–1680.
  14. Bhatt R.K., Hanuman J.B., Sabata B.K. A new clerodane derivative from Tinospora cordifolia. Phytochemistry. 1988; 27:1212–1216.
  15. Hanuman J.B., Bhatt R.K., Sabata B. A clerodane furano-diterpene from Tinospora cordifolia. J. Nat. Prod. 1988; 51:197–201.
  16. Bhatt R.K., Sabata B.K. A furanoid diterpene glucoside from Tinospora cordifolia. Phytochemistry. 1989; 28:2419–2422.
  17. Khan M.A., Gray I.A., Waterman P.G. Tinosporaside an 18-norclerodane glucoside from Tinospora cordifolia. Phytochemistry. 1989; 28:273–275.
  18. Gangan V.D., Arjun P.P., Sipahimalani T., Banerji A., Cardifolisides A., B C. Norditerpene furon glucoside from Tinospora cordifolia. Phytochemistry. 1994; 37:781–786.
  19. Maurya R., Handa S.S. Tinocordifolin, a sesquiterpene from Tinospora cordifolia. Phytochemistry. 1998; 44:1343–1345.
  20. Gangan V.D., Arjun P.P., Sipahimalani A.T., Banerji A. Norditerpene furon glucoside from Tinospora cordifolia. Phytochemistry. 1995; 39:1139–1142.
  21. Wazir V., Maurya R., Kapil R.S. A clerodane furano diterpene glucoside from Tinospora cordifolia. Phytochemistry. 1995; 38:447–449.
  22. Gagan V.D., Pradhan P., Sipahimalan A.T., Banerji A., Palmatosides C F. Diterpene furan glucosides from Tinospora cordifolia-structural elucidation by 2D NMR spectroscopy. Indian J. Chem. 1996;35B:630–634.
  23. Choudhary N., Siddiqui M.B., Azmat S., Khatoon S. Tinospora cordifolia: ethnobotany, phytopharmacology and phytochemistry aspects. IJPSR. 2013; 4:891.
  24. Bisset N.G., Nwaiwu J. Quaternary alkaloids of Tinospora species. Planta Med. 1983; 48:275–279.
  25. Mahajan V.R., Jolly C.I., Kundnani K.M. A new hypoglycaemic agent from Tinospora cordifolia. Indian Drugs. 1985; 23:119–120.
  26. Sarma D.N.K., Khosa R.L., Chansauria J.P.N., Ray A.K. The effect of Tinospora cordifolia on brain neurotransmitters in the stressed rat. Fitoterapia. 1995; 66:421–422.
  27. Pathak A.K., Agarwal A.K., Jain D.C., Sharma R.P., Howarth O.W. NMR studies of 20 hydroxyecdysones, a steroid isolated from Tinospora cordifolia. Indian J. Chem. 1995; 34:674–676
  28. Hanuman J.B., Mishra A.K., Sabata B. A natural phenolic lignan from Tinospora cordifolia Miers. J. Chem. Soc. 1986:1181–1185.
  29. Kidwai A.R., Salooja K.C., Sharma V.N., Siddiqui S. Chemical examination of Tinospora cordifolia. J. Sci. Indian Res. 1949; 8:115–118.
  30. Khaleque A., Maith M.A.W., Huq M.S., K Abul B. Tinospora cordifolia IV. Isolation of heptacosanol, ß sitosterol and three other compounds tinosporine, cordifol and cordifolone. Pakistan J. Sci.Industry Res. 1970;14:481–483.
  31. Dixit S.N., Khosa R.L. Chemical investigations on Tinospora cordifolia (wild.) miers. Indian. J. Appl. Chem. 1971; 34:46–47.
  32. Pathak A.K., Jain D.C., Sharma P.R. Chemistry and biological activities of the genus Tinospora. Int. J. Pharmacogn. 1995; 33:277–287.
  33. Khuda M.Q., Khaleque A., Basar K.A., Rouf M.A., Khan M.A., Roy N. Studies on Tinospora cordifolia II: isolation of tinosporine, tinosporic acid and tinosporol from the fresh creeper. Sci. Res. 1966; 3:9–12.
  34. Khaleque A., Maith M.A.W., Huq M.S., Tinospora cordifolia K.A., III Isolation of tinosporine, heptacosanol, ß sitosterol. Pakistan J. Sci. Industry Res. 1971; 14:481–483.
  35. Maurya R., Wazir V., Tyagi A., Kapil R.S. Clerodane diterpene from Tinospora cordifolia. Phytochemistry. 1995; 38:659–661.
  36. Pradhan P., Gangan V.D., Sipahimalani A.T., Banerji A. Two phytoecdysones from Tinospora cordifolia: structural assignment by 2D NMR spectroscopy. Indian J. Chem. 1997;36B:958–962.
  37. Chintalwar G., Jain A., Sipahimalani A., Banerji A., Sumariwalla P., Ramakrishnan R., Sainis K. An Immunologically active arabinogalactan from Tinospora cordifolia. Phytochemistry. 1999; 52:1089–1093.
  38. Bauer R, Remiger P, Wagner H. Alkamides from the roots of Echinacea purpurea. Phytochemistry. 1988; 27:2339–42.
  39. Hohmann J, Rédei D, Forgo P, Szabó P, Freund TF, Haller J, et al. Alkamides and a neolignan from purpurea roots and the interaction of alkamides with G-protein-coupled cannabinoid receptors. Phytochemistry. 2011; 72:1848–53.
  40. Barnes J, Anderson LA, Gibbons S, Phillipson JD. Echinacea species (Echinacea angustifolia (DC.). Hell, Echinacea pallida (Nutt.) Nutt Echinacea purpurea (L.) Moench): A review of their chemistry, pharmacology and clinical properties. J Pharm Pharmacol. 2005; 57:929–54.
  41. Luo XB, Chen B, Yao SZ, Zeng JG. Simultaneous analysis of caffeic acid derivatives and alkamides in roots and extracts of Echinacea purpurea by high-performance liquid chromatography-photodiode array detection-electrospray mass spectrometry. J Chromatogr A. 2003; 986:73–81.
  42. Wills RB, Stuart DL. Alkylamide and cichoric acid levels in Echinacea purpurea grown in Australia. Food Chem. 1999; 67:385–8.
  43. Classen B, Witthohn K, Blaschek W. Characterization of an arabinogalactan-protein isolated from pressed juice of Echinacea purpurea by precipitation with the beta-glucosyl Yariv reagent. Carbohydr Res. 2000; 327:497–504.
  44. Bohlmann F, Hoffmann H. Further amides from Echinacea purpurea. Phytochemistry. 1983; 22:1173–5.
  45. Khare CP. Encyclopedia of Indian medicinal plants. NewYork: Springes-Verlag Berlin Heidelberg; 2004.
  46. Sharma PC, Yelne MB, Dennis TJ. Database on medicinal plants used in Ayurveda. New Delhi: 2005. pp. 420–440.
  47. Goreja WG. Black seed: nature's miracle remedy. New York, NY: Amazing Herbs Press; 2003.
  48. Al-Bukhari MI. In: The collection of authentic sayings of prophet mohammad (peace be upon him), division 71 on medicine. 2nd ed. Al-Bukhari Sahi., editor. Ankara: Hilal Yayinlari; 1976.
  49. Al-Jassir MS. Chemical composition and microflora of black cumin (Nigella sativa L.) seeds growing in Saudi Arabia. Food Chem. 1992; 45:239–242.
  50. Atta-Ur-Rahman Nigellidine-a new indazole alkaloid from the seed of Nigella sativa. Tetrahedron Lett. 1995;36(12):1993–1994.
  51. Nickavar B, Mojab F, Javidnia K, Amoli MA. Chemical composition of the fixed and volatile oils of Nigella sativa L. from Iran. Z Naturforsch C. 2003;58(9–10):629–631.
  52. Cheikh-Rouhou S, Besbes S, Lognay G, Blecker C, Deroanne C, Attia H. Sterol composition of black cumin (Nigella sativa L.) and Aleppo pine (Pinus halpensis Mill.) seed oils. J Food Comp Anal. 2008;21(2):162–168.
  53. Mehta BK, Verma M, Gupta MJ. Novel lipid constituents identified in seeds of Nigella sativa Linn. Braz Chem Soc. 2008;19(3):458–462.
  54. Bourgou S, Ksouri R, Bellila A, Skandrani I, Falleh H, Marzouk B. Phenolic composition and biological activities of Tunisian Nigella sativa L. shoots and roots. C R Biol. 2008;331(1):48–55.
  55. Nickavar B, Mojab F, Javidnia K, Amoli MA. Chemic al composition of the fixed and volatile oils of Nigella sativa L. from Iran. Z Naturforsch C. 2003;58(9–10):629–631.
  56. Morikawa T, Xu F, Ninomiya K, Matsuda H, Yoshikawa M. N.mines A3, A4, A5 and C, new dolabellane-type diterpene alkaloids with lipid metabolism-promoting activities from the Egyptian medicinal food black cumin. Chem Pharm Bull. 2004;52(4):494–497.
  57. Morikawa T, Xu F, Kashima Y, Matsuda H, Ninomiya K, Oshikawa M. Noveldolabellane-type diterpene alkaloids with lipid metabolism promoting activities from the seeds of Nigella sativa. Org Lett. 2004;6(6):869–872.
  58. Ali Z, Ferreira D, Carvalho P, Avery MA, Khan IA. Nigellidine-4-O-sulfite, the first sulfated indazole-type alkaloid from the seeds of Nigella sativa. J Nat Prod. 2008;71(6):1111–1112.
  59. Mehta BK, Pandit V, Gupta M. New principles from seeds of Nigella sativa. Nat Prod Res. 2009;23(2):138–48.
  60. Shan, T.; Ma, Q.; Guo, K.; Liu, J.; Li, W.; Wang, F.; Wu, E. Xanthones from mangosteen extracts as natural chemopreventive agents: Potential anticancer drugs. Curr. Mol. Med. 2011,11, 666–677.
  61. Nirmal, N.P.; Rajput, M.S.; Prasad, R.G.; Ahmad, M. Brazilin from Caesalpinia sappan heartwood and its pharmacological activities: A review. Asian Pac. J. Trop. Med. 2015,8, 421–430.
  62. Niu, Y.; Wang, S.; Li, C.; Wang, J.; Liu, Z.; Kang, W. Effective compounds from Caesalpinia sappan L. on the tyrosinase in vitro and in vivo. Nat. Prod. Commun. 2020,15, 1934578X20920055. [CrossRef]
  63. Goreja WG. Black seed: nature's miracle remedy. New York, NY: Amazing Herbs Press; 2003.
  64. Al-Ali A, Alkhawajah AA, Randhawa MA, Shaikh NA. Oral and intraperitoneal LD50 of thymoquinone, an active principle of Nigella sativa, in mice and rats. J Ayub Med Coll Abbottabad. 2008;20(2):25–27.
  65. Warrier PK, Nambiar VPK, Ramamurthy. Chennai: Orient Longman Pvt Ltd; 2004. Indian medicinal plants-a compendium of 500 species; pp. 139–142
  66. Al-Jassir MS. Chemical composition and microflora of black cumin (Nigella sativa L.) seeds growing in Saudi Arabia. Food Chem. 1992; 45:239–242.
  67. Atta-Ur-Rahman Nigellidine-a new indazole alkaloid from the seed of Nigella sativa. Tetrahedron Lett. 1995;36(12):1993–1994.
  68. Nickavar B, Mojab F, Javidnia K, Amoli MA. Chemical composition of the fixed and volatile oils of Nigella sativa L. from Iran. Z Naturforsch C. 2003;58(9–10):629–631.
  69. Cheikh-Rouhou S, Besbes S, Lognay G, Blecker C, Deroanne C, Attia H. Sterol composition of black cumin (Nigella sativa L.) and Aleppo pine (Pinus halpensis Mill.) seed oils. J Food Comp Anal. 2008;21(2):162–168.
  70. Mehta BK, Verma M, Gupta MJ. Novel lipid constituents identified in seeds of Nigella sativa Linn. Braz Chem Soc. 2008;19(3):458–462.
  71. Bourgou S, Ksouri R, Bellila A, Skandrani I, Falleh H, Marzouk B. Phenolic composition and biological activities of Tunisian Nigella sativa L. shoots and roots. C R Biol. 2008;331(1):48–55.
  72. Nickavar B, Mojab F, Javidnia K, Amoli MA. Chemic al composition of the fixed and volatile oils of Nigella sativa L. from Iran. Z Naturforsch C. 2003;58(9–10):629–631.
  73. Morikawa T, Xu F, Ninomiya K, Matsuda H, Yoshikawa M. N.mines A3, A4, A5 and C, new dolabellane-type diterpene alkaloids with lipid metabolism-promoting activities from the Egyptian medicinal food black cumin. Chem Pharm Bull. 2004;52(4):494–497.
  74. Morikawa T, Xu F, Kashima Y, Matsuda H, Ninomiya K, Oshikawa M. Novel dolabellane-type diterpene alkaloids with lipid metabolism promoting activities from the seeds of Nigella sativa. Org Lett. 2004;6(6):869–872.
  75. Ali Z, Ferreira D, Carvalho P, Avery MA, Khan IA. Nigellidine-4-O-sulfite, the first sulfated indazole-type alkaloid from the seeds of Nigella sativa. J Nat Prod. 2008;71(6):1111–1112.
  76. Mehta BK, Pandit V, Gupta M. New principles from seeds of Nigella sativa. Nat Prod Res. 2009;23(2):138–48.
  77. Liu YH, Qin GW, Ding SP, et al.  Chemical constituents of isatis root (I). Chin Herb Med 2001; 32(12): 4–7. https://doi.org/CNKI:SUN:ZCYO.0.2001-12-000
  78. Ding SP, Liu YH, Li J, et al.  Study on chemical constituents of isatis root (II). Med J 2001; 020(008): 475–6. 10.3870/j.issn.1004-0781.2001.08.001
  79. Fang JG, Wang SB, Xu H, et al.  Chemical constituents of isatis root (I). Chin Herb Med 2004; 35(8): 9–10. 10.7501/j.issn.0253-2670.2004.8.387.
  80. Liu HL, Wu LJ, Li H, et al.  Chemical constituents of Radix isatidis. J Shenyang Pharm Univ 2002; (02):93–5. 10.3969/j.issn.1006-2858.2002.02.005
  81. Liang Y N, Zhu J, Tang ZS, Sun XC, et al.  Optimization of ultrasonic extraction process and antioxi-dant activity of total flavonoids from Radix isatidis by box Behnken re-sponse surface methodology. J Changchun Univ Trad Chin Med 2019; 35: 119–24. 10.13463/j.cnki.cczyy.2019.01.036
  82. Zhang H J, He LW, Tang M. Molecular docking study on anti influenza virus of flavonoids in isatis root. Chem Time 2018; 32: 19–21. 10.16597/j.cnki.issn.1002-154x.2018.03.007
  83. Zhao WT. Optimization of ultrasonic assisted extraction technology and antioxidant activity of Flavonoids from Isatis indigotica root by response surface methodology. Chin Modern Appl Pharm 2016; 33: 313–7. 10.13748/j.cnki.issn1007-7693.2016.03.013
  84. Liu YH, Ding SP, Wu XY, et al.  Study on chemical constituents of isatis root (III). Chin Herb Med 2002; 33(002): 3–5. 10.7501/j.issn.0253-2670.2002.2.041
  85. Liu YH, Qin GW, Wu XY, et al.  Study on chemical constituents of isatis root (IV). Med J 2003; 22(9): 591–4. https://doi.org/CNKI:SUN:YYDB.0.2003-09-
  86. Chen Y, Fan CL, Wang Y, et al.  Chemical constituents of Radix isatidis. Chin J Trad Chin Med 2018; 43: 2091–6. 10.19540/j.cnki.cjcmm.20180116.001
  87. Liu LF, Li FZ. Chemical composition, pharmacology and quality control management of Radix Isatidis. Chin Health Indu 2018; 15: 36–7. 10.16659/j.cnki.1672-5654.2018.13.036
  88. Sun Q, Zhao J, Zhang SJ, et al. Chemical constituents of isatis root Radix isatidis. Chin J Exp Pharmacol 2012; 18: 74–5. 10.1007/978-1-4020-9623-5-5
  89. Wang XL, Chen MH, Wang F, et al.  Studies on the chemical constituents of Radix isatidis. In: 9th Natural organic chemistry academic conference of China Chemical Society, Haikou, Hainan, China, 2012.
  90. Liu YH, Wu XY, Fang JG, et al.  Study on chemical constituents of Radix isatidis (V). Zhongnan Pharm 2003; 1(5): 302–5. https://doi.org/CNKI:SUN:ZNYX.0.2003-05-017
  91. Yan J. Study on chemical constituents and activity evaluation of radix isatidis and Flaxseed[D]. Jilin University, 2011.
  92. Wang T, Wang X, Zhuo Y, et al.  Antiviral activity of a polysaccharide from Radix isatidis (Isatis indigotica Fortune) against hepatitis B virus (HBV) in vitro via acti-vation of JAK/STAT signal pathway. J Ethnopharmacology 2020;257: 112782. 10.1016/j.jep.2020.112782
  93. Kurihara H, Luo Z, Liu LF, et al.  Isatis indigotica Epigoitrin, an alkaloid from reduces H1N1 infection in stress-induced susceptible model in vivo and in vitro. Front Pharmacol 2019; 10: 78. 10.3389/fphar.2019.00078
  94. Tsai FJ, Hsieh CC, Tsai CH, et al.  Anti-SARS coronavirus 3C-like protease effects of Isatis ndigotica root and plant-derived phenolic compounds. Antiv Res 2005; 68: 36–42. 10.1016/j.antiviral.2005.07.002
  95. Qu RJ, et al.  Selection of reference genes for the quantitative real-time PCR normalization of gene expression in Isatis indigotica fortune. BMC Mol Biol 2019; 20: 9. 10.1186/s12867-019-0126-y
  96. Yan ZH. Clinical practical Chinese medicine[M]. Beijing: People’s Health Publishing House; 1984. ISBN: 14048–519.
  97. Li HY, Li YG, Liang QY, et al.  Extraction and content comparison of indigo and indirubin in Isatis indigotica root, stem and leaf. Guangdong Chem 2016; 43: 27–8. https://doi.org/CNKI:SUN:GDHG.0.2016-02-012.

Photo
Himani Malode
Corresponding author

Vidyabharti College of Pharmacy, C K Naidu Road, Amravati

Photo
Dr. Ajay Baitule
Co-author

Vidyabharti College of Pharmacy, C K Naidu Road, Amravati

Photo
Gayatri Yeole
Co-author

Vidyabharti College of Pharmacy, C K Naidu Road, Amravati

Photo
Jaydeep Wankhade
Co-author

Vidyabharti College of Pharmacy, C K Naidu Road, Amravati

Himani Malode*, Dr. Ajay Baitule, Jaydeep Wankhade, Gayatri Yeole, Pharmacognostical Studies and Clinical Applications of Medicinal Plants as Immunity Booster, Int. J. of Pharm. Sci., 2025, Vol 3, Issue 5, 3835-3853. https://doi.org/10.5281/zenodo.15490499

More related articles
The Surge in Cardiovascular Diseases Post-COVID: P...
Haritha Babu Mm, Prya, Sharanya S., Sharadhi S., Dr. M. Mallikarj...
Navigating Neurological Risks After COVID-19 Vacci...
Arnab Roy, K. Rajeswar Dutt, Ankita Singh, Mahesh Kumar Yadav, Ma...
Navigating Neurological Risks After COVID-19 Vacci...
Arnab Roy, K. Rajeswar Dutt, Ankita Singh, Mahesh Kumar Yadav, Ma...
A Comprehensive Review on Analyzing Adverse Drug Reactions and Stability Profile...
Kaushal Chavan, Yogeshwar Chaudhari, Kiran Rathod, Dipali Chaudhari, Snehal Patil, Vishal Patil, ...
Navigating Neurological Risks After COVID-19 Vaccination Campaign: Insights And ...
Arnab Roy, K. Rajeswar Dutt, Ankita Singh, Mahesh Kumar Yadav, Manav Kumar, Kajal Kumari, Saurabh Ch...
Related Articles
The Surge in Cardiovascular Diseases Post-COVID: Prevalence and Incidence Insigh...
Haritha Babu Mm, Prya, Sharanya S., Sharadhi S., Dr. M. Mallikarjuna Gowda, Dr. Satish S., ...
Tinospora Cordifolia – As An Anticancer Agent: Recent And Advance Study...
Arpita R. Pawar, Ashwini T. Chougule, Jaya R. Kamble, Pritam Salokhe, Nilesh B. Chougule, ...
Formulation Development and Evaluation of Moringa Oleifera Herbal Shampoo ...
Jaydeep Wankhade, Ajay Baitule, Himani Malode , Gayatri Yeole , Gokul Rahate , Gauri Kunjam, ...
A Comprehensive Review on Analyzing Adverse Drug Reactions and Stability Profile...
Kaushal Chavan, Yogeshwar Chaudhari, Kiran Rathod, Dipali Chaudhari, Snehal Patil, Vishal Patil, ...
The Surge in Cardiovascular Diseases Post-COVID: Prevalence and Incidence Insigh...
Haritha Babu Mm, Prya, Sharanya S., Sharadhi S., Dr. M. Mallikarjuna Gowda, Dr. Satish S., ...
More related articles
The Surge in Cardiovascular Diseases Post-COVID: Prevalence and Incidence Insigh...
Haritha Babu Mm, Prya, Sharanya S., Sharadhi S., Dr. M. Mallikarjuna Gowda, Dr. Satish S., ...
Navigating Neurological Risks After COVID-19 Vaccination Campaign: Insights And ...
Arnab Roy, K. Rajeswar Dutt, Ankita Singh, Mahesh Kumar Yadav, Manav Kumar, Kajal Kumari, Saurabh Ch...
Navigating Neurological Risks After COVID-19 Vaccination Campaign: Insights And ...
Arnab Roy, K. Rajeswar Dutt, Ankita Singh, Mahesh Kumar Yadav, Manav Kumar, Kajal Kumari, Saurabh Ch...
The Surge in Cardiovascular Diseases Post-COVID: Prevalence and Incidence Insigh...
Haritha Babu Mm, Prya, Sharanya S., Sharadhi S., Dr. M. Mallikarjuna Gowda, Dr. Satish S., ...
Navigating Neurological Risks After COVID-19 Vaccination Campaign: Insights And ...
Arnab Roy, K. Rajeswar Dutt, Ankita Singh, Mahesh Kumar Yadav, Manav Kumar, Kajal Kumari, Saurabh Ch...
Navigating Neurological Risks After COVID-19 Vaccination Campaign: Insights And ...
Arnab Roy, K. Rajeswar Dutt, Ankita Singh, Mahesh Kumar Yadav, Manav Kumar, Kajal Kumari, Saurabh Ch...